Lead sponsor
Noah Pharmaceuticals, Inc.
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
0
Ongoing
121
Total enrollment
16
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Trials by status
Completed
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of PolypillAlzheimer's diseasePh 2Completed121